In Conversation with Professor Nigel McMillan, Dr Rebecca Huntley and Mik Auckland
After the Pandemic: Imagining the Future Our response to coronavirus will shape Australia for decades to come. It has been...
After the Pandemic: Imagining the Future Our response to coronavirus will shape Australia for decades to come. It has been...
Advanced bionic limb development, malaria drug mechanisms, skin immune response to mosquito-borne infections among new Ideas Grants.
Griffith University has entered into a $135 million commercial partnership with Gene Company o further develop a new drug treatment for SARS-CoV-2, the virus responsible for COVID-19.
Recent advances in technology have brought the promise of gene therapy closer than ever to being realised. One true breakthrough is clustered regularly interspaced short palindromic repeats (CRISPR), it offers a radical new method for gene therapy that builds on decades of science.
A team of international scientists has developed an an experimental direct-acting antiviral to treat COVID-19.
New details of the promising Oxford AstraZeneca vaccine signals hope for 2021 … but what does this actually mean for the general population?
Griffith researchers are among Australia’s most prominent voices of the pandemic.
Using gene-silencing technology Griffith University researchers aim to identify new antiviral drug treatments for COVID-19.
Gene editing technology leads to new cervical cancer breakthrough.
Purpose-built bio-storage facility bridges gap in translational clinical research.